Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
13.09
+0.49 (3.89%)
At close: Jul 2, 2026, 4:00 PM EDT
12.83
-0.26 (-1.99%)
After-hours: Jul 2, 2026, 7:52 PM EDT
Q32 Bio Market Cap
Q32 Bio has a market cap or net worth of $221.96 million as of July 2, 2026. Its market cap has increased by 1,023.27% in one year.
Market Cap
221.96M
Enterprise Value
184.85M
1-Year Change
1,023.27%
Ranking
Category
Stock Price
$13.09
Market Cap Chart
Since March 26, 2024, Q32 Bio's market cap has increased from $199.19M to $221.96M, an increase of 11.43%. That is a compound annual growth rate of 4.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 221.96M | 443.35% |
| Dec 31, 2025 | 40.85M | -2.51% |
| Dec 31, 2024 | 41.90M | -78.96% |
| Mar 26, 2024 | 199.19M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Voyager Therapeutics | 228.39M |
| Protara Therapeutics | 228.19M |
| Whitehawk Therapeutics | 225.35M |
| NervGen Pharma | 225.15M |
| Codexis | 224.51M |
| Coherus Oncology | 223.66M |
| Keros Therapeutics | 222.86M |
| Nautilus Biotechnology | 219.85M |